| 1 day | +3.13% |
| Manager | Title | Age | Since |
|---|---|---|---|
Peter Gerckens
CEO | Chief Executive Officer | 39 | 01/01/2025 |
Michael Rudolf
DFI | Director of Finance/CFO | 52 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Clemens Fischer
CHM | Chairman | 51 | 04/03/2020 |
| Director/Board Member | 45 | 04/03/2020 | |
Axel Rebien
BRD | Director/Board Member | 55 | 01/06/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/14/25 A | Sell | Chairman | 1,315 | 0.0110% | ||
| 8/11/25 A | Sell | Chairman | 39,678 | 0.3306% | ||
| 8/8/25 A | Sell | Chairman | 873 | 0.0073% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.13% | +3.13% | - | - | 447M | ||
| -1.13% | -1.17% | +38.55% | +139.23% | 1,275B | ||
| -1.36% | -0.74% | +39.64% | +86.06% | 680B | ||
| -0.59% | -0.36% | +25.14% | +111.73% | 521B | ||
| -0.76% | +1.10% | +41.43% | +70.96% | 389B | ||
| -0.75% | -3.16% | +54.39% | +40.90% | 356B | ||
| -1.83% | -0.89% | +26.00% | +58.48% | 305B | ||
| -1.65% | -0.59% | +1.55% | +34.52% | 287B | ||
| -0.95% | -1.57% | +34.01% | +72.55% | 250B | ||
| +1.60% | -0.36% | +37.21% | +125.66% | 208B | ||
| Average | -0.43% | -0.37% | +33.10% | +82.23% | 475B | |
| Weighted average by Cap. | -0.98% | -0.55% | +34.96% | +95.62% |
Employees
98
Sector
Pharmaceuticals
















